Reported Oct 25, 2022 · Announced
Mylan Institutional LLC, a Viatris company recalls Mylan Institutional LLC Octreotide Acetate Injection, 500 mcg/mL due to Due to glass particulates
Mylan Institutional LLC, a Viatris company
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
- Octreotide Acetate Injection, 500
- mcg/mL BrandMylan Institutional LLC. Drugs
Why it was recalled
Due to glass particulates
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mylan Institutional LLC, a Viatris company recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.